research peptide FAQ

Use a DPP-IV-resistant VIP analog like [Ro 25-1553] or co-administer a DPP-IV inhibitor (sitagliptin, 10 mg/kg) to extend VIP half-life from 2 minutes to 15–20 minutes in vivo. Alternatively, deliver VIP via osmotic minipump for continuous infusion, which maintains steady-state plasma levels despite rapid clearance. This approach has been validated in allergen-challenged mouse models where continuous VIP infusion (10 µg/kg/hr) reduced airway hyperresponsiveness by 52% over 7 days.

Persistent cloudiness after two minutes of gentle swirling indicates either peptide aggregation or the presence of insoluble excipients. Do not use cloudy solutions. Aggregated peptides have unpredictable bioavailability and may trigger immune responses in cell culture or animal models. Filter the solution through a 0.22 µm sterile syringe filter as a diagnostic step: if cloudiness clears, the issue was particulate contamination; if it persists, the peptide itself has aggregated and the vial should be discarded.

It would not change the availability of research-grade SS-31, but it could expand access to clinical-grade elamipretide if the new indication achieved approval. FDA approval is indication-specific: even if SS-31 were approved for Barth syndrome, off-label prescribing for primary mitochondrial myopathy would remain at physician discretion. Research-grade suppliers would continue to offer the peptide for laboratory use regardless of clinical approval status.

Verify peptide integrity first. VIP loses 40–60% activity after a single freeze-thaw cycle or 24 hours at room temperature. Reconstitute fresh VIP in sterile PBS at pH 7.2–7.4 immediately before the assay. If the issue persists, confirm VPAC receptor expression in your tissue. Some immortalised cell lines downregulate VPAC2 after prolonged passage. Use RT-PCR or Western blot to verify receptor presence before concluding VIP is ineffective.

Peptides below 95% purity contain meaningful levels of synthesis byproducts, truncated sequences, or deletion peptides that interfere with receptor binding and introduce variability across doses. A 92% purity result means 8% of the vial's mass is not KPV. That is not acceptable for reproducible research. Request a refund or replacement from a supplier offering ≥98% purity. For context, Real Peptides maintains a minimum 98% purity threshold across our entire peptide line, including KPV 5MG, verified by third-party HPLC.

Bacteriostatic water costs $8–$12 per 30ml vial and alcohol prep pads cost $6–$10 per box of 100. These are one-time or low-frequency purchases that add $0.50–$1.00 per dose initially but become negligible across multi-month protocols. Syringes (insulin syringes, 0.5ml or 1ml) cost $12–$18 per box of 100, adding $0.12–$0.18 per injection. Total ancillary cost per dose is approximately $0.65–$1.20, which should be added to per-vial cost when calculating true monthly KPV cost per month budget.

State plainly: 'It's a research peptide called SS-31, used for mitochondrial function studies, prescribed by my physician.' Then hand over the prescriber letter immediately. Do not use jargon ('mitochondrial-targeted Szeto-Schiller peptide'), do not oversell the compound's benefits ('it's for heart health'), and do not mention off-label or experimental use unless the letter explicitly states it. TSA officers are trained to escalate anything that sounds evasive or overly technical. They're not evaluating the science, they're confirming you have legitimate authorization. If the officer asks to open the cooler, let them. If they ask about the vial's contents, reference the prescriber letter and offer to show the packaging label if it's from a compounding pharmacy. Most secondary inspections last 3–5 minutes and end with the officer running the vial through additional imaging or a swab test for explosives residue. Peptides don't trigger explosive detection, so the swab clears immediately.

Freeze the reconstituted vial immediately at -20°C to extend stability beyond the 28-day refrigerated window. Frozen reconstituted peptides maintain potency for 90–120 days, though repeated freeze-thaw cycles degrade protein structure. Limit to one freeze and one thaw per vial. The alternative is to delay reconstitution entirely: lyophilized KPV stored at -20°C remains stable for 12–24 months, so if you anticipate protocol interruptions, purchase vials but reconstitute them only as needed rather than preparing the full month's supply upfront.

Any temperature excursion above 8°C for more than 2–4 hours compromises SS-31's peptide structure. If your medication cooler's temperature indicator shows the vial exceeded range, the conservative answer is to discard it upon arrival and use a backup vial if you carried one. Attempting to salvage heat-exposed peptide wastes the rest of the trip. There's no home test that confirms potency after thermal denaturation. Carry a backup vial for trips longer than 48 hours or routes with known delay risk (regional connections, winter weather hubs). Store the backup separately in a second cooler or insulated sleeve. If the primary vial fails temperature control, you still have coverage. Real-world experience: travelers who carry one vial face a binary outcome (it works or it doesn't), while those carrying two vials have redundancy that eliminates the anxiety of a single point of failure.

No. Marketing SS-31 for human consumption outside an FDA-approved clinical trial or approved drug indication violates the Federal Food, Drug, and Cosmetic Act. Supplements must either qualify as dietary ingredients under DSHEA or receive FDA approval as drugs. SS-31 meets neither criterion. Any supplier marketing it for human use is operating illegally. Researchers should only source from suppliers that explicitly restrict sales to qualified institutions for non-clinical research.

Tarmac delays are the highest-risk event for peptide transport because cabin ventilation is reduced and temperatures can climb rapidly. If your passive cooling system was rated for 24 hours and you're three hours into a delay, you likely still have margin. But verify with your temperature logger after landing. Active cooling systems (USB refrigerators) should continue running off battery power during ground delays. If the delay exceeds your cooling system's rated duration, inform the lead flight attendant that you're transporting temperature-sensitive research material and request permission to access the aircraft's refrigeration (galleys have units maintaining 2–8°C for food service). This is a reasonable accommodation under ADA medical necessity provisions, though not guaranteed.

Do not use it. Yellow, brown, or grey discolouration indicates oxidative degradation. The peptide structure has been compromised and will not deliver consistent results. Clumpy or fluffy powder dispersed across the vial suggests incomplete lyophilisation or moisture exposure during storage. Contact the supplier immediately with photos and request a replacement with documented storage conditions. Legitimate suppliers replace degraded vials without requiring return shipping because the visual evidence is definitive.

Extend at half the initial loading dose. 7.5mg weekly instead of 15mg. To maintain plasma levels without the cost burden of full loading doses. This consumes 6 vials monthly instead of 12, reducing the extended loading month from $780 to $390 at bulk pricing. The biological rationale: tissue regeneration markers plateau after four weeks of high-dose administration, but maintaining elevated TB-4 concentrations for an additional 2–4 weeks can support collagen remodeling in chronic injury models.

Purchase multiple vials and reconstitute only what you'll use within 28 days. A protocol requiring 15mg monthly should reconstitute one 10mg vial immediately and store the second vial lyophilised at −20°C until needed. This maintains peptide stability and prevents waste from expired reconstituted solution. Bulk purchases of 5+ vials from Real Peptides reduce per-vial cost by 12–18%, lowering your effective KLOW cost per month budget at higher consumption levels.

Batch-order 3–6 months of supply in a single shipment to amortize shipping costs across multiple vials. Cold-chain shipping for peptides typically costs $15–$25 per order regardless of vial quantity, meaning a single-vial monthly order pays $15/month in shipping while a six-vial order pays $2.50/month per vial. Store unopened lyophilized vials at -20°C and reconstitute sequentially. The upfront capital outlay is higher, but total cost per dose drops by 12–18% compared to monthly ordering.

International travel adds customs documentation and import restrictions. SS-31 isn't a controlled substance under the UN Single Convention, but individual countries regulate research peptides differently. Canada requires an import permit for unapproved biologics unless you're carrying fewer than 90 days' supply with prescriber authorization. The EU treats research peptides as investigational medicinal products. You'll need a medical necessity letter and possibly advance notification to customs. Check the destination country's pharmaceutical import rules 4–6 weeks before departure. The embassy or consulate website typically lists import requirements for medications and biologics. If the country requires advance approval, submit the prescriber letter, product specification sheet (showing SS-31 is a research peptide, not a controlled drug), and your travel dates. Processing times range from 7–21 days depending on the jurisdiction.

Without documentation, TSA officers have discretion to refuse passage of unlabeled vials or research materials. Your options: (1) Have your PI or lab manager email a scanned copy of the letter, display it on your phone, and request the officer accept the digital version. Some will, many won't. (2) If you have your institutional ID and the peptide has a labeled vial with a pharmacy or supplier name, explain it's for research use and provide contact information for your lab. The officer may allow passage with supervisor approval. (3) If all else fails, you may need to ship the peptide via FedEx Cold Chain or similar service and continue your travel without it. Never lie about the contents or claim it's a personal medication when it's a research compound. Misrepresentation is a federal offense and will result in confiscation and potential criminal referral.

Choose verified peptides and reduce dosing frequency or sample size before choosing unverified sources. An experiment conducted with degraded or impure peptide yields unusable data. Forcing you to re-purchase verified peptide and repeat the study, doubling both cost and timeline. The KLOW cost per month budget from Real Peptides is 15–25% higher than unverified suppliers, but the failure rate is effectively zero. Failed experiments cost more than premium peptides.

Source peptides from Real Peptides. Small-batch synthesis with exact amino-acid sequencing guarantees purity above 98%, which is critical when dose-response precision matters. For in vitro work, 1–5 mg aliquots are sufficient for months of organ bath or cell culture experiments. For in vivo models, budget 10–20 mg per study depending on dosing frequency and animal cohort size. Aliquot immediately upon receipt to avoid degradation from repeated handling.

Partially thawed gel packs are classified as liquids under TSA rules and will be confiscated if they don't meet the frozen-solid standard at screening. If this happens, your reconstituted peptide will exceed safe temperature within hours. The mitigation strategy is to freeze backup gel packs and pack them separately in checked luggage if allowed, or locate a pharmacy or hotel with refrigerator access immediately after clearing security to transfer the vial into cold storage until you can source replacement ice. Lyophilized DSIP avoids this risk entirely. If temperature control during air travel is uncertain, transport the peptide in powder form and reconstitute at your destination instead.